Cardiovascular diseases (CVD) are one of the foremost public health challenge across the globe. According to World Organization (WHO) estimate, about 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. Around one third of CVD deaths take place in the low and middle income countries. By the year 2030, more than 23 million people are likely to die annually from cardiovascular diseases. There is an unmet market need for better diagnostics and therapeutics to prevent the mortality from CVDs. Major factors driving the global cardiac equipment market are, rising geriatric population along with higher incidence of coronary artery diseases, stroke, heart failure, hypertension and diabetes. Furthermore, unhealthy sedentary lifestyle, smoking tobacco, and the high intake of salt and cholesterol, supplement the developments in this market. However, the high cost of treatment and a stringent regulatory environment, are likely to restrain the market growth.
The global cardiac equipment market is segmented on the basis of type and geography. On the basis of type, the market is segmented into, Balloon pumps, Cardiopulmonary bypass pumps, Cardiac ultrasound devices, Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT) Devices such as CRT Pacemaker (CRT-P) and CRT Defibrillator (CRT-D), Defibrillators Pacemakers, Ventricular assist devices and others such as Total Artificial Heart and Counterpulsation Devices. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.
New product approval and launch are among the few strategies adopted by top industry players. In April 2015, HeartWare International procured the Canadian marketing approval for HeartWare Ventricular Assist System, a small circulatory support device. Similarly, Philips has recently launched VesselNavigator, a 3D Navigation System intended for minimally invasive treatments of vascular diseases. In March 2014, St. Jude Medical announced the approval of three pacemakers, Allure Quadra CRT-P, Assurity and Endurity pacemakers. The companies profiled in this report include, Medtronic plc, Boston Scientific Corporation, St. Jude Medical, Inc., Thoratec Corporation, HeartWare Inc., SynCardia Systems, Inc., Vasomedical, Inc., Sorin Group, Biotronik, Inc. and Berlin Heart, Inc.
KEY MARKET BENEFITS
KEY MARKET SEGMENT:
The global cardiac equipment market is segmented below:
Global Cardiac Equipment Market - By Type
Global Cardiac Equipment Market - By Geography
SIMILAR MARKET STUDIES
Glucose Meter is a medical device for determining the approximate concentration of glucose in the blood. It can also be a strip of glucose paper dipped into a substance and measured to the glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes ...
September 2017 | $4880 | View Details >>
This report studies the Pet Insurance market, Pet insurance is a type of specialty property and casualty insurance policy that pet owners purchase to cover the unintended costs that arise in providing care for a pet, including veterinary services such as surgical procedures, injuries from accidents, and prescribed pet medicines. ...
September 2017 | $4880 | View Details >>
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Biofeedback Instrument in these regions, from 2012 to 2022 (forecast), covering North America Europe China Asia (Ex. China) RoW The major players in global Biofeedback Instrument market include Thought Technology Ltd Laborie Qxsubspace Vishee Quantum World Vision BrainMaster Technologies, Inc. Mind Media NeuroCare Allengers Medical Systems ELMIKO NCC ...
September 2017 | $2900 | View Details >>
This report studies the Irreversible Electroporation Ablators market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Irreversible Electroporation Ablators market by product type and applications/end industries. The ...
September 2017 | $4000 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research